[Elsevier] Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial |
|
This post will be closed automatically in 2026-06-23 00:06
Best Answer
Half hour(s) ago
|
| |
10
How does the carbon emission trading scheme affect enterprise cost of equity capital? Evidence from China
10
Data-driven and computational insights into borophene: Integrating machine learning with DFT and AI
10
Outcomes of Lesions With Discordance Between FFR and Nonhyperemic Pressure Ratios
10
In-silico design of metal-ion batteries: Unleashing the potential of conductive polymer functionalized boron nitride nanosheets
10
A DFT study on nano-voids enhanced lithium storage capacity in Li4Ti5O12 anodes for lithium-ion batteries
